Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology and Therapeutics|January 12, 2017
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transportersK Yang, C Battista, J L Woodhead, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2012
Serum proteomic profiling in patients with drug-induced liver injuryL N Bell, R Vuppalanchi, P B Watkins, et al.
Molecular Pharmacology|September 1, 1985
Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the ratS A Wrighton, E G Schuetz, P B Watkins, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasiaS J Hughes, M A Morse, C M Weghorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liverD T Molowa, E G Schuetz, S A Wrighton, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activityP B Watkins, D K Turgeon, P Saenger, et al.
Transplantation|March 1, 1992
Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?J C Kolars, P L Stetson, B D Rush, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayersJ M Fisher, S A Wrighton, P B Watkins, et al.
Gastroenterology|June 26, 1999
Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteersR J Fontana, K S Lown, M F Paine, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1995
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variabilityA Lampen, U Christians, F P Guengerich, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology and Therapeutics|January 12, 2017
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transportersK Yang, C Battista, J L Woodhead, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2012
Serum proteomic profiling in patients with drug-induced liver injuryL N Bell, R Vuppalanchi, P B Watkins, et al.
Molecular Pharmacology|September 1, 1985
Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the ratS A Wrighton, E G Schuetz, P B Watkins, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasiaS J Hughes, M A Morse, C M Weghorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liverD T Molowa, E G Schuetz, S A Wrighton, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activityP B Watkins, D K Turgeon, P Saenger, et al.
Transplantation|March 1, 1992
Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?J C Kolars, P L Stetson, B D Rush, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayersJ M Fisher, S A Wrighton, P B Watkins, et al.
Gastroenterology|June 26, 1999
Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteersR J Fontana, K S Lown, M F Paine, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1995
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variabilityA Lampen, U Christians, F P Guengerich, et al.
Pageof 10